ABX-CBL antibody to CBL: Phase II

Abgenix Inc. (ABGX), Fremont, Calif. Product: ABX-CBL antibody to CBL ( CD147) antigen on immune cells Indication: Treat severe graft-versus-host disease (GvHD) Status: ABGX completed a Phase II trial...